Charles Schwab Investment Management Inc. Has $68,000 Stock Position in Outlook Therapeutics, Inc. (NASDAQ:OTLK)
Charles Schwab Investment Management Inc. lessened its position in shares of Outlook Therapeutics, Inc. (NASDAQ:OTLK – Free Report) by 29.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 36,048 shares of the company’s stock after selling 15,411 shares during the quarter. Charles […]
Charles Schwab Investment Management Inc. lessened its position in shares of Outlook Therapeutics, Inc. (NASDAQ:OTLK – Free Report) by 29.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 36,048 shares of the company’s stock after selling 15,411 shares during the quarter. Charles […]
